Klavax BID 875 mg + 125 mg filmom obložene tablete
| Name | Klavax BID 875 mg + 125 mg filmom obložene tablete |
|---|---|
| Former Name | Klavax BID 1 g tablete |
| Marketing Authorisation Number | HR-H-366753663 |
| Active Substance | amoksicilin trihidrat kalijev klavulanat |
| Composition | jedna filmom obložena tableta sadržava 875 mg amoksicilina u obliku amoksicilin trihidrata i 125 mg klavulanske kiseline u obliku kalijevog klavulanata |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | mibe GmbH Arzneimittel, Brehna, Njemačka |
| Marketing Authorisation Holder | Mibe Pharmaceuticals d.o.o., Zavrtnica 17, Zagreb, Hrvatska |
| Marketing Authorisation Date | 10.01.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/14-02/139 |
| Registration Number | 381-12-01/38-20-52 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | neponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | J01CR02 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
